Loading…
SyntheticMR AB signed an agreement to acquire all shares of Finnish medical technology company Combinostics Oy for EUR 4.3 million, subject to approval by an Extraordinary General Meeting.
“The acquisition is a strategic step in SyntheticMR's growth plan and is designed to strengthen the Company's market position and future competitiveness.”news.cision.com
Summarized from public sources; check the original articles before acting on it.